These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2056586)

  • 1. Inhibition of prostatic tumor cell proliferation by suramin: alterations in TGF alpha-mediated autocrine growth regulation and cell cycle distribution.
    Kim JH; Sherwood ER; Sutkowski DM; Lee C; Kozlowski JM
    J Urol; 1991 Jul; 146(1):171-6. PubMed ID: 2056586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop.
    Schrell UM; Gauer S; Kiesewetter F; Bickel A; Hren J; Adams EF; Fahlbusch R
    J Neurosurg; 1995 Apr; 82(4):600-7. PubMed ID: 7897522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor alpha.
    Hofer DR; Sherwood ER; Bromberg WD; Mendelsohn J; Lee C; Kozlowski JM
    Cancer Res; 1991 Jun; 51(11):2780-5. PubMed ID: 2032218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
    Boylan M; van den Berg HW; Lynch M
    Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine growth stimulation by transforming growth factor-alpha in human non-small cell lung cancer.
    Putnam EA; Yen N; Gallick GE; Steck PA; Fang K; Akpakip B; Gazdar AF; Roth JA
    Surg Oncol; 1992 Feb; 1(1):49-60. PubMed ID: 1341235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine regulation of DU145 human prostate cancer cell growth by epidermal growth factor-related polypeptides.
    Connolly JM; Rose DP
    Prostate; 1991; 19(2):173-80. PubMed ID: 1923964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Androgen regulation of secreted growth factors in prostate carcinoma cell and tumor lines].
    Kellner U; Wagner B; Otto U; Voigt KD; Dietel M; Knabbe C
    Verh Dtsch Ges Pathol; 1993; 77():124-8. PubMed ID: 7511269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgenic regulation of growth factor and growth factor receptor expression in the CWR22 model of prostatic adenocarcinoma.
    Myers RB; Oelschlager D; Manne U; Coan PN; Weiss H; Grizzle WE
    Int J Cancer; 1999 Jul; 82(3):424-9. PubMed ID: 10399960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells.
    Seth D; Shaw K; Jazayeri J; Leedman PJ
    Br J Cancer; 1999 May; 80(5-6):657-69. PubMed ID: 10360641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The enhancement of the chemotherapeutic effects on human prostate cancer cell--the combination with the growth factor interaction inhibitor (suramin)].
    Suzuki Y; Miwa Y; Akino H; Fujita T; Saikawa S; Kanimoto Y; Okada K
    Hinyokika Kiyo; 1993 Dec; 39(12):1215-20. PubMed ID: 8285172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of transforming growth factor beta on human prostate cancer cells in vitro.
    Wilding G; Zugmeier G; Knabbe C; Flanders K; Gelmann E
    Mol Cell Endocrinol; 1989 Mar; 62(1):79-87. PubMed ID: 2545487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproliferative effects of suramin on androgen responsive tumour cells.
    Berns EM; Schuurmans AL; Bolt J; Lamb DJ; Foekens JA; Mulder E
    Eur J Cancer; 1990 Apr; 26(4):470-4. PubMed ID: 2141513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of suramin on the mitogenic response of the human prostate carcinoma cell line PC-3.
    Ewing MW; Liu SC; Gnarra JR; Walther MM; Meyers CE; Linehan WM
    Cancer; 1993 Feb; 71(3 Suppl):1151-8. PubMed ID: 8428338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synergistic and antagonistic effects of cytotoxic and biological agents on the in vitro antitumour effects of suramin.
    Lopez Lopez R; van Rijswijk RE; Wagstaff J; Pinedo HM; Peters GJ
    Eur J Cancer; 1994; 30A(10):1545-9. PubMed ID: 7833116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ionizing radiation-induced mitogen-activated protein (MAP) kinase activation in DU145 prostate carcinoma cells: MAP kinase inhibition enhances radiation-induced cell killing and G2/M-phase arrest.
    Hagan M; Wang L; Hanley JR; Park JS; Dent P
    Radiat Res; 2000 Apr; 153(4):371-83. PubMed ID: 10760996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth factor/growth factor receptor loops in autocrine growth regulation of human prostate cancer DU145 cells.
    Ligęza J; Ligęza J; Klein A
    Acta Biochim Pol; 2011; 58(3):391-6. PubMed ID: 21887406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor.
    Brass AL; Barnard J; Patai BL; Salvi D; Rukstalis DB
    Cancer Res; 1995 Jul; 55(14):3197-203. PubMed ID: 7606741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suramin inhibits growth and transforming growth factor-beta 1 (TGF-beta 1) binding in osteosarcoma cell lines.
    Kloen P; Jennings CL; Gebhardt MC; Springfield DS; Mankin HJ
    Eur J Cancer; 1994; 30A(5):678-82. PubMed ID: 8080687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of growth factors, steroid and peptide hormones in the regulation of human prostatic tumor growth.
    Motta M; Dondi D; Moretti RM; Montagnani Marelli M; Pimpinelli F; Maggi R; Limonta P
    J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):107-11. PubMed ID: 8603030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suramin interrupts androgen-inducible autocrine loop involving heparin binding growth factor in mouse mammary cancer (Shionogi carcinoma 115) cells.
    Kasayama S; Saito H; Kouhara H; Sumitani S; Sato B
    J Cell Physiol; 1993 Feb; 154(2):254-61. PubMed ID: 7678839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.